Nano Drug Delivery Research Center, Kermanshah University of Medical Sciences, Kermanshah, 6734667149, Iran.
Department of Applied Chemistry, Faculty of Chemistry, Razi University, Kermanshah, 6714967346, Iran.
Pharm Res. 2019 Mar 8;36(4):62. doi: 10.1007/s11095-019-2597-4.
The aim of this study is to show a new mesomicroscopic insight into Letrozole (LTZ) loaded nanocomplexes and their ex vivo characteristics as a drug delivery system.
The LTZ loaded hybrid chitosan-based carrier was fabricated using a modified ionic crosslinking technique and characterized in more detail. To understand the mechanism of LTZ action encapsulated in the hybrid polymer-lipid carrier, all-atom molecular dynamics simulations were also used.
The physicochemical properties of the carrier demonstrated the uniform morphology, but different drug loading ratios. In vitro cytotoxic activity of the optimized carrier demonstrated IC of 67.85 ± 0.55 nM against breast cancer cell line. The ex vivo study showed the positive effect of nanocomplex on LTZ permeability 7-10 fold greater than the free drug. The molecular dynamic study also confirmed the prsence of hydrophobic peak of lipids at a distance of 5 Å from the center of mass of LTZ which proved drug entrapment in the core of nanocomplex.
The hybrid nanoparticle increased the cytotoxicity and tissue permeability of LTZ for oral delivery. This study also confirmed the atomic mesostructures and interaction of LTZ in the core of hybrid polymer-lipid nanoparticles.
本研究旨在展示来曲唑(LTZ)负载纳米复合物的新介观见解及其作为药物传递系统的体外特性。
使用改良的离子交联技术制备 LTZ 负载的混合壳聚糖载体,并进行更详细的表征。为了了解包封在混合聚合物-脂质载体中的 LTZ 的作用机制,还使用了全原子分子动力学模拟。
载体的物理化学性质表现出均匀的形态,但药物载药量不同。优化载体的体外细胞毒性活性显示对乳腺癌细胞系的 IC 为 67.85 ± 0.55 nM。体外研究表明,纳米复合物对 LTZ 通透性的积极影响比游离药物高 7-10 倍。分子动力学研究还证实了脂质在距离 LTZ 质心 5 Å 的位置存在疏水峰,这证明了药物被包埋在纳米复合物的核心中。
该混合纳米粒子提高了 LTZ 的细胞毒性和组织通透性,用于口服给药。本研究还证实了 LTZ 在混合聚合物-脂质纳米粒子核心中的原子介观结构和相互作用。